White House strikes new deals to lower prices on obesity drugs for some

Sydney Lupkin

November 07, 2025 / 1:56 am

The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.

Why you can trust KUOW

Get Local Stories

Delivered to your inbox daily, weekly, or monthly.

Explore Newsletters

White House strikes new deals to lower prices on obesity drugs for some

Recommended Stories

Thousands of Washington state Medicare users could soon have claims denied by AI

WA fines Regence Blue Shield $550K over shortfalls with mental health coverage

These Seattle-area clinics plan to take care of people who’ve lost their health insurance

Get Local Stories

Delivered to your inbox daily, weekly, or monthly.